Verastem, Inc. (VSTM) to Present at East/West CEO and J.P. Morgan Healthcare Conferences  
1/3/2013 6:29:04 AM

Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the management team will be presenting at several upcoming conferences.